Estradiol-17beta, Its Hydroxylated and Methoxylated Metabolites, Stimulates Proliferation of Uterine Artery Endothelial Cells from Pregnant Sheep.
Sheikh O. Iobe,Jill M. Koch,Jayanth Ramadoss,Yizhou Jiang,Jing Zheng,Ronald R. Magness
DOI: https://doi.org/10.1093/biolreprod/81.s1.405
2009-01-01
Biology of Reproduction
Abstract:Uterine blood flow is elevated during high estrogen states such as pregnancy. We have previously reported that estrogen results in significant vasodilatation and an increase in uterine blood flow during late gestation. However, its role in uterine angiogenesis is less well studied. Moreover, it is unknown if estradiol 17β (E2β) metabolites which are elevated during pregnancy and are synthesized by cytochrome (CYP) P450 1A1 (CYP1A1), 1A2 (CYP1A2), 1B1 (CYP1B1), and catechol-O-methyltransferase (COMT) to form 2-hydroxyestradiol (2-OHE), 4-hydroxyestradiol (4-OHE), 2-methoxestradiol (2-ME), and 4-methoxyestradiol (4-ME) respectively play a role in modulation of uterine angiogenesis and/or blood flow. In the present study, we tested the hypothesis that E2β, its hydroxylated as well as its methoxylated metabolites, will have an angiogenic role in late gestation uterine artery endothelial cells (UAECs) and that the respective enzymes that metabolize E2β are present in these cells. Validated UAECs from late pregnant sheep (day 120-130; term= 147 days; n=5) were treated with vehicle (control, basal media) or increasing concentrations (0.1-100nM) of E2β, 2-OHE, 4-OHE and 2-ME. An In vitro index of cell proliferation was evaluated utilizing the BrdU Proliferation Assay technique following the subsequent 24 hrs of treatment. Furthermore, the presence of the CYP and COMT enzymes was evaluated by immunofluorescent staining and multi-photon confocal imaging. E2βtreatment significantly induced UAEC proliferation (P< 0.0001). Pos-hoc tests revealed maximum response at a physiological E2β concentration of 0.1 nM (P< 0.001, magnitude of response, 2.67 + 0.23 fold of control). Treatment with 2-OHE, and 4-OHE resulted in equivalent significant increases in proliferation (P< 0.0001; maximal responses 1.79 + 0.06 fold of control). In contrast, 2-ME resulted in only a minor increases in UAEC proliferation levels (P= 0.0037). Post hoc tests revealed maximum response at 0.1 nM 2-ME (P < 0.05; maximal response at 1.30 + 0.02 fold of control). Multi photon confocal imaging revealed the presence of CYP1A2, CYP1B1 and COMT, in the cytoplasmic domain of these cells. However, we did not detect CYP1A1. These data demonstrate a potential role of E2β and its metabolites in regulating uterine angiogenesis. These data show for the first time, the presence of estrogen metabolizing enzymes in the uterine artery endothelial cells. Collectively, our findings are suggestive that E2β, its hydroxylated and methoxylated metabolites, may play an important role in maternal uterine adaptation to pregnancy through participation in uterine angiogenesis. NIH HL49210, HD38843, HL87144 & HL64703. (poster)